ORPHAI

Owner

Goods & Services

Development of pharmaceutical preparations and medicines; Genetic engineering; Laboratory research in the field of gene expression; Medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Medical, pharmaceutical, and biopharmaceutical research services; Non-downloadable computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis; Pharmaceutical, medical, scientific, and biopharmaceutical research and development; Providing medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Providing research and development relating to pharmaceutical, medical, scientific, and biopharmaceutical; Research in the field of gene therapy; Scientific and medical research in the fields of gene, genome, and genomic editing, modulation, transcription, to develop human pharmaceutical and biopharmaceutical preparations; Scientific research for medical purposes in the field of cancerous diseases; Scientific research in the field of genetics

Recorded computer software featuring deep learning algorithms and AI for pharmaceutical, medical, scientific, and biopharmaceutical research and development and analysis, none of the foregoing for design, test and implementation

Medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and rare diseases, namely, Amyotrophic Lateral Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Sarcoidosis, Bronchiolitis Obliterans; Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; Pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases; Pharmaceutical, medical, scientific, and biopharmaceutical research and development